A novel and unique protein i-body for the treatment of chronic kidney disease through targeting CXCR4 [ 2018 - 2021 ]

Research Grant

Researchers: Prof Carol Pollock (Principal investigator) ,  A/Pr Michael Foley ,  A/Pr Xin-Ming Chen

Brief description Chronic kidney disease (CKD) is a worldwide public health problem, with adverse outcomes of kidney failure, cardiovascular disease, and premature death. Kidney transplantation and dialysis are the only options for the management of CKD, which results in a significant burden on the health system. The central aim of this project is to develop a novel therapeutic strategy to limit/reverse CKD, which will lead to a researcher-industry partnership in discovery of novel therapeutic agent.

Funding Amount $AUD 779,096.76

Funding Scheme Project Grants

Notes Standard Project Grant